Table 3 Retear rate
Authors (Year, level of evidence) | No of patients in the accelerated group (AG) and conservative group (CG)a | No of retear (%) |
|---|---|---|
Arndt et al. [61] (2012, II) | AG (49) | 11 (23.3 %) |
CG (43) | 7 (15.4 %) | |
Cuff et al. [70] (2012, I) | AG (33) | 5 (15 %) |
CG (35) | 3 (8 %) | |
De Roo et al. [110] (2015, I) | AG (79) | 0 (0 %) |
CG (51) | 2 (4 %) | |
Düzgün et al. [29] (2014, II) | AG (19) | 0 (0 %) |
CG (21) | 0 (0 %) | |
Keener et al. [63] (2014, I) | AG (61) | 6 (10 %) |
CG (53) | 3 (6 %) | |
Kim et al. [64] (2012, I) | AG (56) | 7 (12 %) |
CG (49) | 9 (18 %) | |
Koh et al. [77] (2014, I) | AG (40) | 5 (12.5 %) |
CG (48) | 4 (8.3 %) | |
Lee et al. [67] (2012, II) | AG (30) | 7 (23 %) |
CG (34) | 3 (8.8 %) | |
Mazzocca et al. [68] (2017, II) | AG (31) | 11 (34 %) |
CG (27) | 9 (31 %) | |
Sheps et al. [79] (2019, I) | AG (103) | 5 (4.9 %) |
CG (103) | 4 (3.9 %) |